Additional file 3 of Clinical trials and drug cost savings for Italian health service

Figshare2020-12-03 更新2026-04-08 收录

数据链接：

https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Clinical_trials_and_drug_cost_savings_for_Italian_health_service/13294379 数据链接链接失效反馈

官方服务：

资源简介：

Additional file 3. Synthetic experimental and conventional treatment database.

创建时间：

2020-11-27

Custo-efetividade do Monlupiravir contra infecção de COVID-19 em pacientes idosos e imunossurpimidos [Cost-effectiveness of Monlupiravir against COVID-19 infection in elderly and immunosuppressed patients]

药物经济学评估

卫生技术评估

Trata-se do repositório de versões do modelo completo de análise de custo-efetividade do Monlupiravir contra infecção de COVID-19 em pacientes idosos e imunossurpimidos elaborado pelo Núcleo de Avali

NIAID Data Ecosystem80

Table 1_Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: network meta-analysis and budget impact analysis.docx

药物经济学评估

COVID-19治疗

IntroductionRemdesivir (RDV) and nirmatrelvir/ritonavir (NRM/RTV) are two antiviral agents for treating outpatient adults with mild to moderate symptomatic COVID-19 at high risk of developing a severe

NIAID Data Ecosystem10

Budesonide with multi-matrix technology as second-line treatment for ulcerative colitis: evaluation of long-term cost-effectiveness in the Netherlands

药物经济学评估

结肠炎治疗

Aims: Budesonide with multi-matrix technology (MMX) is an oral corticosteroid, shown to have high topical activity against ulcerative colitis (UC) while maintaining low systemic bioavailability

Taylor & Francis Group2019-03-27 更新10

Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease

药物经济学评估

血管疾病治疗

BACKGROUND: Low molecular weight heparins hold several advantages over unfractionated heparin including convenience of administration. Enoxaparin is one such heparin licensed in the UK for use in unst

PubMed Central2001-10-15 更新30

Differences in healthcare resource utilization and direct medical costs of patients with rheumatoid arthritis (RA) before and after the use of multiple biologic agents-Switched.

药物经济学评估

类风湿关节炎治疗管理

Differences in healthcare resource utilization and direct medical costs of patients with rheumatoid arthritis (RA) before and after the use of multiple biologic agents-Switched.

Figshare2018-07-18 更新10

Additional file 3 of Clinical trials and drug cost savings for Italian health service

资源简介：

相关数据集